Linolenic Acid

Linolenic Acid

SCHEMBL104456

CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)[O-].[Na+]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Linolenic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 2/20 0.69
PPARG known ✓ P37231 2/20 0.69
PTGS2 known ✓ P35354 1/20 0.69
ADORA3 known ✓ P0DMS8 1/20 0.58
FABP3 P05413 9/20 0.96
ALDH1A1 P00352 5/20 0.69
F7 P08709 3/20 0.69
F3 P13726 3/20 0.69
CYP19A1 P11511 3/20 0.69
MAPT P10636 2/20 0.69
CYP3A4 P08684 2/20 0.69
ALOX15 P16050 2/20 0.69
HSD17B10 Q99714 2/20 0.69
TDP1 Q9NUW8 2/20 0.69
OXER1 Q8TDS5 2/20 0.69
KMT2A Q03164 2/20 0.69
PPARD Q03181 2/20 0.69
PPARA Q07869 2/20 0.69
KDM4E B2RXH2 1/20 0.69
MEN1 O00255 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Docosapentaenoic Acid SCHEMBL29908522 1.00 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
SCHEMBL25403260 1.00 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
SCHEMBL29908521 0.98 FABP3 (0.93) FABP3ALDH1A1F7F3CYP19A1
SCHEMBL25402321 0.98 FABP3 (0.93) FABP3ALDH1A1F7F3CYP19A1
Linolenic Acid SCHEMBL4853105 0.96 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
Linolenic Acid SCHEMBL4918659 0.96 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
Linolenic Acid SCHEMBL4921337 0.96 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
Linolenic Acid SCHEMBL6140641 0.96 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
Linolenic Acid SCHEMBL2410422 0.96 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1
Linolenic Acid SCHEMBL4409873 0.96 FABP3 (0.96) FABP3ALDH1A1F7F3CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1032 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4127119-B1 WATER-GLYCOL HYDRAULIC FLUID SHELL INT RESEARCH (NL) 2025-08-27 EP claimed
US-20250178919-A1 PROCESS FOR THE PRODUCTION OF NANOCRYSTALS OF METAL CHALCOHALIDES FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-06-05 US claimed
WO-2025093572-A1 SOLID DISPERSION COMPOSITIONS AND USES THEREOF TRx Biosciences Limited (GB) 2025-05-08 WO claimed
CN-119677509-A Fibrate composition for the treatment of inflammation and neuroinflammation 特瑞克思生物科学有限公司 2025-03-21 CN claimed
EP-4493151-A2 COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS AND USES THEREOF TRX Biosciences Limited (GB) 2025-01-22 EP claimed
CN-119216105-A Magnesite collector, magnesite desilication purification method and magnesite concentrate 宜丰国轩锂业有限公司 2024-12-31 CN claimed
CN-119186827-A Phosphorite double reverse flotation method 三亚城投众辉新型建材有限公司 2024-12-27 CN claimed
EP-4472927-A1 PROCESS FOR THE PRODUCTION OF NANOCRYSTALS OF METAL CHALCOHALIDES Consiglio Nazionale delle Ricerche (IT) 2024-12-11 EP claimed
CN-119097567-A Whitening and freckle-removing essence and preparation method thereof 广州匠心生物科技研究有限公司 2024-12-10 CN claimed
CN-115380102-B Water-glycol hydraulic fluid 国际壳牌研究有限公司 2024-03-22 CN claimed
US-7345093-B2 Methods of enhancing solubility of compounds FORMATECH, INC. (US) 2008-03-18 US claimed
EP-1748759-A2 METHODS OF ENHANCING SOLUBILITY IN WATER OF HYDROPHOBIC COMPOUNDS BY MICELLAR DISPERSIONS FORMATECH, INC. (US) 2007-02-07 EP claimed
US-7137975-B2 Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent ACIONT, INC. (US) 2006-11-21 US claimed
WO-2005105041-A2 METHODS OF ENHANCING SOLUBILITY IN WATER OF HYDROPHOBIC COMPOUNDS BY MICELLAR DISPERSIONS FORMATECH, INC. (US) 2005-11-10 WO claimed
US-20050238673-A1 Methods of enhancing solubility of compounds JAVERI, INDU 2005-10-27 US claimed
US-20020161323-A1 Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent ACIONT INC. 2002-10-31 US claimed
US-5980947-A MIXING SOLVENT CONTAINING A MIXTURE OF AT LEAST ONE WATER INSOLUBLE SOLVENT AND AT LEAST ONE WATER-MISCIBLE SOLVENT WITH A FATTY ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT TO FORM OIL PHASE; SUSTAIN RELEASING PEPTIDE OR ANTITUMOR AGENTAGENT EISAI CO., LTD. (JP) 1999-11-09 US claimed
EP-0461630-B1 Production process of microspheres EISAI CO LTD (JP) 1995-09-13 EP claimed
EP-0461630-A2 Production process of microspheres Eisai Co., Ltd. (JP) 1991-12-18 EP claimed
US-4542789-A MIXTURE OF UREA AND THE SODIUM SALT OF AN UNSATURATED CARBOXYLIC ACID; ENHANCED OIL RECOVERY PHILLIPS PETROLEUM COMPANY (US) 1985-09-24 US claimed